小于胎龄早产儿胆汁淤积症的临床特征及危险因素

陈瑜; 朱雪萍

doi:10.7499/j.issn.1008-8830.2404095

PDF(574 KB)

HTML

中国当代儿科杂志 ›› 2024, Vol. 26 ›› Issue (10) : 1027-1033. DOI: 10.7499/j.issn.1008-8830.2404095

论著·临床研究

小于胎龄早产儿胆汁淤积症的临床特征及危险因素

陈瑜^1,2, 朱雪萍¹

作者信息 +

Clinical features and risk factors of cholestasis in small for gestational age preterm infants

CHEN Yu, ZHU Xue-Ping

Author information +

文章历史 +

摘要

目的探讨小于胎龄（small for gestational age infant, SGA）早产儿胆汁淤积症临床特征及其发生的高危因素。方法选取胎龄<37周且在出生24?h内收住苏州大学附属儿童医院新生儿科的SGA早产儿为研究对象，将其分为胆汁淤积症和非胆汁淤积症两组，收集并回顾性分析2017年7月—2022年6月的临床数据。结果纳入的553例SGA早产儿中，100例（18.1%）发生胆汁淤积症。不同胎龄和出生体重组别的发生率分别为：超早产儿50.0%，极早产儿46.6%，中期早产儿32.7%，晚期早产儿9.8%；出生体重（birth weight, BW）<1 000?g 60.9%，1 000?g≤BW<1 500?g 33.9%，1 500 g≤BW<2 500?g 10.7%。多因素回归分析显示，低出生体重、颅内出血、有创通气时间、第2周氨基酸累积量、第1周脂肪乳累积量、第2周脂肪乳累积量是SGA早产儿发生胆汁淤积症的独立危险因素（P<0.05）。结论 SGA早产儿胆汁淤积症的发生率随胎龄和出生体重的降低而升高；SGA早产儿胆汁淤积症的发生受低出生体重、颅内出血、有创通气及氨基酸、脂肪乳累积量等多种危险因素综合影响，需采取综合治疗措施减少其发生。

Abstract

Objective To investigate the clinical features and risk factors of cholestasis in small for gestational age (SGA) preterm infants. Methods This study selected SGA preterm infants born at less than 37 weeks of gestation and admitted to the Department of Neonatology, Children's Hospital of Soochow University within 24 hours after birth. The infants were divided into two groups: a cholestasis group and a non-cholestasis group. Clinical data from July 2017 to June 2022 were collected and retrospectively analyzed. Results Among the 553 SGA preterm infants included, 100 infants (18.1%) developed cholestasis. The incidence rates in different gestational age and birth weight groups were as follows: extremely preterm infants 50.0%, very preterm infants 46.6%, moderate preterm infants 32.7%, and late preterm infants 9.8%; birth weight (BW) <1 000?g 60.9%, 1 000?g≤BW<1 500?g 33.9%, and 1 500?g≤BW<2 500?g 10.7%. Multivariate regression analysis showed that low birth weight, intracranial hemorrhage, duration of invasive ventilation, total amino acid accumulation in the second week, total lipid emulsion accumulation in the first week, and total lipid emulsion accumulation in the second week were independent risk factors for cholestasis in SGA preterm infants (P<0.05). Conclusions The incidence of cholestasis in SGA preterm infants increases with decreasing gestational age and birth weight. The occurrence of cholestasis in SGA preterm infants is influenced by multiple risk factors, including low birth weight, intracranial hemorrhage, invasive ventilation, and the accumulation of amino acids and lipid emulsions, highlighting the need for comprehensive treatment measures to reduce its occurrence.

导出引用

陈瑜, 朱雪萍. 小于胎龄早产儿胆汁淤积症的临床特征及危险因素[J]. 中国当代儿科杂志. 2024, 26(10): 1027-1033 https://doi.org/10.7499/j.issn.1008-8830.2404095

CHEN Yu, ZHU Xue-Ping. Clinical features and risk factors of cholestasis in small for gestational age preterm infants[J]. Chinese Journal of Contemporary Pediatrics. 2024, 26(10): 1027-1033 https://doi.org/10.7499/j.issn.1008-8830.2404095

参考文献

1 王庆红, 杨于嘉, 魏克伦, 等. 我国小于胎龄儿现状分析[J]. 中国实用儿科杂志, 2009, 24(3): 177-180.
2 Lee SM, Namgung R, Park MS, et al. Parenteral nutrition associated cholestasis is earlier, more prolonged and severe in small for gestational age compared with appropriate for gestational age very low birth weight infants[J]. Yonsei Med J, 2013, 54(4): 839-844. PMID: 23709416. PMCID: PMC3663238. DOI: 10.3349/ymj.2013.54.4.839.
3 乐英彪, 王昆华, 邹雷. 牛磺胆酸促进肝硬化发展的机制[J]. 临床肝胆病杂志, 2021, 37(11): 2658-2662. DOI: 10.3969/j.issn.1001-5256.2021.11.037.
4 陈瑞玲, 马雄. 胆汁淤积导致肝纤维化的机制及其阻断策略[J]. 临床肝胆病杂志, 2019, 35(2): 247-251. DOI: 10.3969/j.issn.1001-5256.2019.02.002.
5 张启迪, 陆伦根. 胆汁淤积致肝纤维化的机制及治疗[J]. 临床肝胆病杂志, 2015, 31(3): 337-341. DOI: 10.3969/j.issn.1001-5256.2015.03.005.
6 史君兰, 赵有丽, 卢苗. 婴儿胆汁淤积性肝炎临床表现与预后的关系[J]. 肝脏, 2019, 24(6): 722-723. DOI: 10.3969/j.issn.1008-1704.2019.06.049.
7 孙小卉. 新生儿胃肠外营养相关性胆汁淤积的危险因素研究[J]. 黑龙江科学, 2021, 12(22): 62-63. DOI: 10.3969/j.issn.1674-8646.2021.22.024.
8 章晔, 许云仙, 李娜, 等. 新生儿胃肠外营养相关性胆汁淤积症的危险因素分析[J]. 中国食物与营养, 2021, 27(10): 70-74. DOI: 10.3969/j.issn.1006-9577.2021.10.014.
9 Lauriti G, Zani A, Aufieri R, et al. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review[J]. JPEN J Parenter Enteral Nutr, 2014, 38(1): 70-85. PMID: 23894170. DOI: 10.1177/0148607113496280.
10 Shin JI, Namgung R, Park MS, et al. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?[J]. Eur J Pediatr, 2008, 167(2): 197-202. PMID: 17436017. DOI: 10.1007/s00431-007-0454-7.
11 Frazer LC, Gura KM, Bines JE, et al. Prevention and management of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in the critically ill infant[J]. World Rev Nutr Diet, 2021, 122: 379-399. PMID: 34352771. DOI: 10.1159/000514763.
12 Wang N, Yan W, Hong L, et al. Risk factors of parenteral nutrition-associated cholestasis in very-low-birthweight infants[J]. J Paediatr Child Health, 2020, 56(11): 1785-1790. PMID: 32100397. DOI: 10.1111/jpc.14826.
13 Robinson DT, Ehrenkranz RA. Parenteral nutrition-associated cholestasis in small for gestational age infants[J]. J Pediatr, 2008, 152(1): 59-62. PMID: 18154901. DOI: 10.1016/j.jpeds.2007.06.002.
14 Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition[J]. J Pediatr Gastroenterol Nutr, 2017, 64(1): 154-168. PMID: 27429428. DOI: 10.1097/MPG.0000000000001334.
15 Dani C, Pratesi S, Raimondi F, et al. Italian guidelines for the management and treatment of neonatal cholestasis[J]. Ital J Pediatr, 2015, 41: 69. PMID: 26428285. PMCID: PMC4591626. DOI: 10.1186/s13052-015-0178-7.
16 丁瑞伟, 李娟. 早产儿胆汁淤积症影响因素及结局[J]. 国际儿科学杂志, 2021, 48(6): 414-419. DOI: 10.3760/cma.j.issn.1673-4408.2021.06.012.
17 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019.
18 Tufano M, Nicastro E, Giliberti P, et al. Cholestasis in neonatal intensive care unit: incidence, aetiology and management[J]. Acta Paediatr, 2009, 98(11): 1756-1761. PMID: 19664101. DOI: 10.1111/j.1651-2227.2009.01464.x.
19 Catzola A, Vajro P. Management options for cholestatic liver disease in children[J]. Expert Rev Gastroenterol Hepatol, 2017, 11(11): 1019-1030. PMID: 28745070. DOI: 10.1080/17474124.2017.1359538.
20 Yan W, Hong L, Wang Y, et al. Retrospective dual-center study of parenteral nutrition-associated cholestasis in premature neonates: 15 years' experience[J]. Nutr Clin Pract, 2017, 32(3): 407-413. PMID: 28135431. DOI: 10.1177/0884533616687532.
21 Wang YS, Shen W, Yang Q, et al. Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: a multicenter observational study[J]. BMC Pediatr, 2023, 23(1): 250. PMID: 37210514. PMCID: PMC10199576. DOI: 10.1186/s12887-023-04068-0.
22 李静, 郑葵阳, 张蓓蓓. 胆汁酸代谢调节胆汁淤积性肝病的作用机制及药物研发[J]. 临床肝胆病杂志, 2021, 37(10): 2482-2487. DOI: 10.3969/j.issn.1001-5256.2021.10.048.
23 王陈红, 施丽萍, 吴秀静, 等. 早产儿胃肠外营养相关性胆汁淤积症的临床特征[J]. 中华儿科杂志, 2011, 49(3): 199-202. PMID: 21575370. DOI: 10.3760/cma.j.issn.0578-1310.2011.03.010.
24 王亚红, 周莲娟, 朱姗姗. 危重症早产儿胃肠外营养相关胆汁淤积的病例特点和影响因素分析[J]. 中国妇幼保健, 2021, 36(15): 3565-3567. DOI: 10.19829/j.zgfybj.issn.1001-4411.2021.15.047.
25 Diderholm B. Perinatal energy metabolism with reference to IUGR & SGA: studies in pregnant women & newborn infants[J]. Indian J Med Res, 2009, 130(5): 612-617. PMID: 20090116.
26 Garg M, Devaskar SU. Glucose metabolism in the late preterm infant[J]. Clin Perinatol, 2006, 33(4): 853-870. PMID: 17148009. DOI: 10.1016/j.clp.2006.10.001.
27 Zambrano E, El-Hennawy M, Ehrenkranz RA, et al. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases[J]. Pediatr Dev Pathol, 2004, 7(5): 425-432. PMID: 15547767. DOI: 10.1007/s10024-001-0154-7.
28 武梦骅, 赵艳男, 郑峥. 不同胎龄早产儿喂养不耐受影响因素分析[J]. 中南医学科学杂志, 2017, 45(2): 160-164. DOI: 10.15972/j.cnki.43-1509/r.2017.02.013.
29 Kleinman RE, Berseth C, Castillo-Duran C, et al. Perinatal nutrition and gastrointestinal disorders: working group report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition[J]. J Pediatr Gastroenterol Nutr, 2004, 39 Suppl 2: S703-S710. PMID: 15184772. DOI: 10.1097/00005176-200406002-00018.
30 刘云凤. 早产极低出生体重儿胃肠外营养相关性胆汁淤积临床特征[D]. 杭州: 浙江大学, 2017.
31 舒国琴. 败血症、低血糖与新生儿坏死性小肠结肠炎风险的相关性分析[J]. 河南医学研究, 2020, 29(14): 2555-2557. DOI: 10.3969/j.issn.1004-437X.2020.14.022.
32 唐良晟, 唐朝晖. 脓毒症早期胆汁淤积发生机制的研究进展[J]. 中华危重病急救医学, 2021, 33(4): 506-508. PMID: 34053501. DOI: 10.3760/cma.j.cn121430-20201109-00707.
33 El Kasmi KC, Anderson AL, Devereaux MW, et al. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease[J]. Sci Transl Med, 2013, 5(206): 206ra137. PMID: 24107776. PMCID: PMC4070735. DOI: 10.1126/scitranslmed.3006898.
34 钟小毅, 杨冬菲, 孙东明, 等. 早产小于胎龄儿发生的危险因素分析[J]. 医学研究与教育, 2023, 40(1): 59-63. DOI: 10.3969/j.issn.1674-490X.2023.01.009.
35 Sharma D, Shastri S, Farahbakhsh N, et al. Intrauterine growth restriction: part 1[J]. J Matern Fetal Neonatal Med, 2016, 29(24): 3977-3987. PMID: 26856409. DOI: 10.3109/14767058.2016.1152249.
36 冯巍, 刘荣添, 陈家颖. 晚期早产儿中小于胎龄儿与适于胎龄儿的临床特点分析[J]. 中国医药科学, 2021, 11(6): 22-25.
37 林秋兰, 林垦. 78例小于胎龄儿的临床特点分析[J]. 实用临床医学, 2020, 21(2): 51-53. DOI: 10.13764/j.cnki.lcsy.2020.02.020.
38 杨常栓, 李瑞雪, 金晓艳, 等. 早产小于胎龄儿的临床特点分析[J]. 中国医刊, 2023, 58(8): 906-909. DOI: 10.3969/j.issn.1008-1070.2023.08.025.